G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2498147
The invention relates to the application of kallikrein (11), free PSA, and total PSA in the detection of prostate cancer. These markers may be used for the diagnosis, monitoring, staging, progression, prevention, treatment, and prognosis of prostate cancer, and as indicators before surgery or after relapse. A particular aspect of the invention provides a method for distinguishing prostate cancer from benign prostatic hyperplasia (BPH).
L'invention concerne l'application de kallicréine 11, d'antigène prostatique spécifique (PSA) libre et d'antigène prostatique spécifique (PSA) total dans la détection du cancer de la prostate. Ces marqueurs peuvent être utilisés dans le diagnostic, la surveillance, le bilan d'extension, la progression, la prévention, le traitement et le pronostic du cancer de la prostate et en tant qu'indicateurs avant une intervention chirurgicale ou après une rechute. Un aspect spécifique de l'invention a trait à une méthode de distinction du cancer de la prostate d'une hyperplasie prostatique bénigne.
Mccarthy Tetrault Llp
Mount Sinai Hospital
LandOfFree
Methods for detecting prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1508225